Chronic Pain Treatment Market Report 2026

Chronic Pain Treatment Market Overview

• Chronic Pain Treatment market size has reached to $109.05 billion in 2025 • Expected to grow to $168.99 billion in 2030 at a compound annual growth rate (CAGR) of 9.1% • Growth Driver: Rising Prevalence Of Arthritis Pain Is Fueling The Market Growth Due To Increasing Aging Population And Musculoskeletal Conditions • Market Trend: Enhancing Chronic Pain Management With Adaptive Neuromodulation Technology • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Chronic Pain Treatment Market?

Chronic pain treatment refers to the ongoing management of pain that persists for more than three months, often beyond the expected period of healing. It typically involves a combination of medications, physical therapy, psychological support, and lifestyle changes to reduce pain intensity, improve function, and enhance quality of life. The main product types of chronic pain include drugs and devices. Drugs for chronic pain are medications that relieve persistent pain by targeting inflammation, nerve signals, or underlying causes to improve patients’ quality of life. These drugs are used for various indications such as neuropathic pain, arthritis pain, chronic back pain, cancer pain, migraine, fibromyalgia, and other conditions. They are distributed through various channels, including direct and indirect distribution, and are used by a range of end-users such as hospitals, clinics, nursing homes, research centers and universities, and others.

What Is The Chronic Pain Treatment Market Growth Forecast?

The chronic pain treatment market size is expected to see strong growth in the next few years. It will grow to $168.99 billion in 2030 at a compound annual growth rate (CAGR) of 9.1%. The growth in the forecast period can be attributed to opioid regulation, device-based therapies, chronic disease prevalence, mental health integration, outpatient pain care growth. Major trends in the forecast period include shift toward non-opioid pain therapies, growth of neuromodulation devices, expansion of multidisciplinary pain management, increased focus on personalized pain care, integration of psychological support therapies.

Global Chronic Pain Treatment Market Segmentation

1) By Product Type: Drugs, Devices 2) By Indication: Neuropathic Pain, Arthritis Pain, Chronic Back Pain, Cancer Pain, Migraine, Fibromyalgia, Other Indications 3) By Distribution channels: Direct, Indirect 4) By End-User: Hospitals, Clinics, Nursing Homes, Research Centers And Universities, Other End-Users Subsegments: 1) By Drugs: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Opioids, Antidepressants, Anticonvulsants, Muscle Relaxants, Topical Analgesics, Other Pain Relief Medications 2) By Devices: Neuromodulation Devices, Transcutaneous Electrical Nerve Stimulation (TENS) Devices, Spinal Cord Stimulators, Peripheral Nerve Stimulators, Radiofrequency Ablation Devices, Implantable Drug Delivery Devices

What Is The Driver Of The Chronic Pain Treatment Market?

The rising prevalence of arthritis pain is expected to propel the growth of the chronic pain treatment market going forward. Arthritis pain refers to the discomfort, aching, or soreness in the joints caused by inflammation or degeneration due to arthritis. The rising prevalence of arthritis pain is primarily driven by the aging population, as joint wear and tear naturally increase with age, leading to a greater incidence of arthritis-related conditions. Chronic pain treatment helps arthritis pain by targeting inflammation and nerve sensitivity to reduce discomfort, improve joint function, and enhance overall quality of life for individuals living with persistent arthritis symptoms. For instance, in July 2024, according to the Centers for Disease Control and Prevention, a US-based government agency, an estimated 21.2% of adults aged 18 and older in the US were diagnosed with arthritis in 2023. Therefore, the rising prevalence of arthritis pain is driving the growth of the chronic pain treatment industry.

Key Players In The Global Chronic Pain Treatment Market

Major companies operating in the chronic pain treatment market are Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, Abbott Laboratories, Novartis AG, GlaxoSmithKline plc, Medtronic plc, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim International GmbH, Boston Scientific Corporation, Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Amneal Pharmaceuticals LLC, Mallinckrodt plc, Nevro Corp.

Global Chronic Pain Treatment Market Trends and Insights

Major companies operating in the chronic pain treatment market are focusing on developing innovative solutions, such as closed-loop spinal cord stimulation (SCS) systems, to meet the rising demand for advanced non-opioid therapies, better long-term pain control and improved patient quality of life. Closed-loop SCS systems are implantable, rechargeable neurostimulators that continuously sense neural signals and automatically adjust electrical stimulation in real time, unlike traditional open-loop SCS devices that deliver preset and non-responsive output. For instance, in April 2024, Medtronic plc, an Ireland-based medical device company, received U.S. Food and Drug Administration (FDA) approval for the Inceptiv Neurostimulation System. The device is a compact rechargeable implant that uses sensing electrodes to monitor evoked neural responses and automatically adjust stimulation. It provides full-body 1.5T and 3T MRI access with impedance-independent sensing and is indicated for chronic, intractable trunk or limb pain. It is designed to deliver more consistent pain relief, better responder outcomes and improved comfort compared with traditional fixed-output SCS systems.

What Are Latest Mergers And Acquisitions In The Chronic Pain Treatment Market?

In May 2025, electroCore Inc., a US-based bioelectronic technology company, acquired NeuroMetrix Inc. for an undisclosed amount. With this acquisition, electroCore aims to strengthen its leadership in the non-invasive bioelectronic therapy market by integrating the Quell platform, expanding its product offerings, and accelerating growth in the chronic pain and wellness segments, particularly within the VA Hospital System. NeuroMetrix Inc. is a US-based medical technology company that develops non-invasive therapeutic devices for chronic pain conditions such as fibromyalgia.

Regional Insights

North America was the largest region in the chronic pain treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Chronic Pain Treatment Market?

The chronic pain treatment market consists of revenues earned by entities by providing services such as pharmacological treatment, physical therapy, psychological counseling, interventional pain management, alternative therapies, pain management clinics, and telehealth services. The market value includes the value of related goods sold by the service provider or included within the service offering. The chronic pain treatment market also includes sales of lyrica, cymbalta, oxycontin, neurontin, voltaren gel, quell, and precision spectra spinal cord stimulator. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Chronic Pain Treatment Market Report 2026?

The chronic pain treatment market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the chronic pain treatment industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.